CP12-0711: A Phase 2, Non-randomized, Open-label, Multicenter Study of IMC-1121B in the Treatment of Persistent or Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma

Grants and Contracts Details

StatusFinished
Effective start/end date3/1/092/28/12

Funding

  • ImClone Systems: $1,000.00